These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 11365973)

  • 21. Anti-HIV agents. Saquinavir with fosamprenavir.
    TreatmentUpdate; 2004; 16(3):9. PubMed ID: 17219609
    [No Abstract]   [Full Text] [Related]  

  • 22. Soft-gel saquinavir now available.
    AIDS Patient Care STDS; 1998 Feb; 12(2):146. PubMed ID: 11361914
    [No Abstract]   [Full Text] [Related]  

  • 23. Long-term efficacy and safety of twice-daily saquinavir soft gelatin capsules (SGC), with or without nelfinavir, and three times daily saquinavir-SGC, in triple combination therapy for HIV infection: 100-week follow-up.
    Greenberg RN; Feinberg J; Goodrich J; Pilson RS; Siemon-Hryczyk P
    Antivir Ther; 2003 Feb; 8(1):37-42. PubMed ID: 12713062
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Drug interactions. Coming soon--a new formulation of saquinavir (Invirase).
    TreatmentUpdate; 2006; 18(3):9. PubMed ID: 17209243
    [No Abstract]   [Full Text] [Related]  

  • 25. Anti-HIV agents. Promising results from a saquinavir study.
    TreatmentUpdate; 2007 Jan; 19(1):9-10. PubMed ID: 17390482
    [No Abstract]   [Full Text] [Related]  

  • 26. Pharmacokinetics and pharmacodynamics of saquinavir in pediatric patients with human immunodeficiency virus infection.
    Grub S; Delora P; Lüdin E; Duff F; Fletcher CV; Brundage RC; Kline MW; Calles NR; Schwarzwald H; Jorga K
    Clin Pharmacol Ther; 2002 Mar; 71(3):122-30. PubMed ID: 11907486
    [TBL] [Abstract][Full Text] [Related]  

  • 27. NIH studies link between saquinavir and garlic pills.
    AIDS Alert; 2002 Feb; 17(2):26. PubMed ID: 11862747
    [No Abstract]   [Full Text] [Related]  

  • 28. Lottery opens 2,000 slots for protease trial.
    AIDS Alert; 1995 Nov; 10(11):144. PubMed ID: 11362929
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy of low-dose boosted saquinavir once daily plus nucleoside reverse transcriptase inhibitors in pregnant HIV-1-infected women with a therapeutic drug monitoring strategy.
    Lopez-Cortes LF; Ruiz-Valderas R; Rivero A; Camacho A; Marquez-Solero M; Santos J; García-Lazaro M; Viciana P; Rodriguez-Baños J; Ocampo A
    Ther Drug Monit; 2007 Apr; 29(2):171-6. PubMed ID: 17417070
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetics, safety and efficacy of saquinavir/ ritonavir 1,000/100 mg twice daily as HIV type-1 therapy and transmission prophylaxis in pregnancy.
    von Hentig N; Nisius G; Lennemann T; Khaykin P; Stephan C; Babacan E; Staszewski S; Kurowski M; Harder S; Haberl A
    Antivir Ther; 2008; 13(8):1039-46. PubMed ID: 19195329
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetic interaction between rifampicin and the once-daily combination of saquinavir and low-dose ritonavir in HIV-infected patients with tuberculosis.
    Ribera E; Azuaje C; Lopez RM; Domingo P; Curran A; Feijoo M; Pou L; Sánchez P; Sambeat MA; Colomer J; Lopez-Colomes JL; Crespo M; Falcó V; Ocaña I; Pahissa A
    J Antimicrob Chemother; 2007 Apr; 59(4):690-7. PubMed ID: 17307771
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ritonavir-saquinavir dual protease inhibitor compared to ritonavir alone in human immunodeficiency virus-infected patients.
    Michelet C; Ruffault A; Sébille V; Arvieux C; Jaccard P; Raffi F; Bazin C; Chapplain JM; Chauvin JP; Dohin E; Cartier F; Bellissant E
    Antimicrob Agents Chemother; 2001 Dec; 45(12):3393-402. PubMed ID: 11709314
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Steady-state pharmacokinetics of a double-boosting regimen of saquinavir soft gel plus lopinavir plus minidose ritonavir in human immunodeficiency virus-infected adults.
    Ribera E; Lopez RM; Diaz M; Pou L; Ruiz L; Falcó V; Crespo M; Azuaje C; Ruiz I; Ocaña I; Clotet B; Pahissa A
    Antimicrob Agents Chemother; 2004 Nov; 48(11):4256-62. PubMed ID: 15504850
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anti-HIV agents. Atazanavir and saquinavir.
    TreatmentUpdate; 2004; 16(3):9-10. PubMed ID: 17219610
    [No Abstract]   [Full Text] [Related]  

  • 35. [FPV plus SQV plus a mini-dose ritonavir. "Double boosting with compatible partners].
    MMW Fortschr Med; 2004 Apr; 146 Spec No 1():92-3. PubMed ID: 15373070
    [No Abstract]   [Full Text] [Related]  

  • 36. European hurdles for saquinavir.
    J Int Assoc Physicians AIDS Care; 1995 Dec; 1(11):44. PubMed ID: 11363099
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Absence of resistance mutations in antiretroviral-naive patients treated with ritonavir-boosted saquinavir.
    Ananworanich J; Hirschel B; Sirivichayakul S; Ubolyam S; Jupimai T; Prasithsirikul W; Chetchotisakd P; Kiertiburanakul S; Munsakul W; Raksakulkarn P; Tansuphasawadikul S; Schutz M; Snowden W; Ruxrungtham K;
    Antivir Ther; 2006; 11(5):631-5. PubMed ID: 16964832
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quadruple-2 protease inhibitors (PI)-therapy does not accelerate viral decay and suppression in PI-naive HIV-1 infected patients with severe immunosuppression and high viral load as compared with standard triple therapy.
    Portilla J; Boix V; Garcia-Henarejos JA; Llopis C; Martínez-Madrid O; Gimeno A; Sánchez-Paya J; Merino E
    Int J STD AIDS; 2005 Dec; 16(12):807-10. PubMed ID: 16336763
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anti-HIV agents. Starting therapy with saquinavir.
    TreatmentUpdate; 2007 Jan; 19(1):8-9. PubMed ID: 17393566
    [No Abstract]   [Full Text] [Related]  

  • 40. Double boosted protease inhibitors, saquinavir, and lopinavir/ritonavir, in nucleoside pretreated children at 48 weeks.
    Kosalaraksa P; Bunupuradah T; Engchanil C; Boonrak P; Intasan J; Lumbiganon P; Burger D; Ruxrungtham K; Schutz M; Ananworanich J;
    Pediatr Infect Dis J; 2008 Jul; 27(7):623-8. PubMed ID: 18520443
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.